Back
Mineralys Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
MLYS
Mineralys Therapeutics, Inc.
Last Price:
$36.85
Seasonality Move:
41.51%
7 Day Trial
ALL ACCESS PASS
$
7
Mineralys Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Mineralys Therapeutics, Inc. has on average historically risen by 128.6% based on the past 2 years of stock performance.
-
Mineralys Therapeutics, Inc. has risen higher in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Mineralys Therapeutics, Inc. Stock Undervalued?The current Mineralys Therapeutics, Inc. [MLYS] share price is $36.83. The Score for MLYS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
MLYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Mineralys Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Mineralys Therapeutics, Inc. has on average historically risen by 128.6% based on the past 2 years of stock performance.
Mineralys Therapeutics, Inc. Stock Rating
Sell
39
Mineralys Therapeutics, Inc. (MLYS)
is a Sell
Is Mineralys Therapeutics, Inc. overpriced?
-
Mineralys Therapeutics, Inc. has risen higher in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Mineralys Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
mineralystx.com
52-Week Data
52-Week High:
47.65
52-Week Low:
8.24
Prediction Charts
Market Cap:
2.9B
Price in USD:
36.83
Volume:
6.2M
Beta:
0.39
Technical Analysis
SMA50:
40.75
SMA100:
33.96
SMA200:
24.23
52-Wk Change:
211.33%
Stock Predictions
-
Is Mineralys Therapeutics, Inc. stock public?Yes, Mineralys Therapeutics, Inc. is a publicly traded company.
-
What is the Mineralys Therapeutics, Inc. stock quote today?The Mineralys Therapeutics, Inc. stock price is 36.83 USD today.
-
How to buy Mineralys Therapeutics, Inc. stock online?You can buy Mineralys Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 40.30 | 39.15 | 40.77 | 39.00 |
| Dec-3 | 39.52 | 39.20 | 40.60 | 39.00 |
| Dec-4 | 38.74 | 38.91 | 39.84 | 38.29 |
| Dec-5 | 39.50 | 38.50 | 39.72 | 37.61 |
| Dec-8 | 39.22 | 38.20 | 39.22 | 37.77 |
| Dec-9 | 38.16 | 36.73 | 38.28 | 36.63 |
| Dec-10 | 36.46 | 36.20 | 38.24 | 35.77 |
| Dec-11 | 36.04 | 36.05 | 36.99 | 35.78 |
| Dec-12 | 36.45 | 36.90 | 39.15 | 35.87 |
| Dec-15 | 36.77 | 36.02 | 37.90 | 35.73 |
| Dec-16 | 35.89 | 36.04 | 37.17 | 35.85 |
| Dec-17 | 36.24 | 37.02 | 37.82 | 36.22 |
| Dec-18 | 37.24 | 37.00 | 37.83 | 36.01 |
| Dec-19 | 37.35 | 36.83 | 38.40 | 36.16 |
Mineralys Therapeutics, Inc. Earnings
Mineralys Therapeutics, Inc. Earnings Report: Per Share Mineralys Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Mineralys Therapeutics, Inc. Forecast Revenue Growth
Mineralys Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Mineralys Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.28 per share, and an increase next year of $0.06 per share.
* Mineralys Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.